Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 152,406 | 178,689 | 133,359 | 120,027 | 161,405 |
| Marketable Securities | N/A | 111,421 | 58,685 | N/A | N/A |
| TOTAL | $157,208 | $292,722 | $194,237 | $124,127 | $165,654 |
| Non-Current Assets | |||||
| PPE Net | 8,706 | 7,242 | 7,742 | 10,100 | 11,765 |
| Investments And Advances | 101 | 1,766 | 1,647 | 725 | 166 |
| Other Non-Current Assets | 62,774 | 69,388 | 68,523 | 64,139 | 10,522 |
| TOTAL | $71,581 | $78,396 | $77,912 | $74,964 | $22,453 |
| Total Assets | $228,789 | $371,118 | $272,149 | $199,091 | $188,107 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 3,347 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,241 | 4,278 | 2,374 | 2,912 | 1,765 |
| Accrued Expenses | 7,668 | 15,410 | 10,716 | 6,838 | 6,517 |
| TOTAL | $18,695 | $35,956 | $29,820 | $17,305 | $21,343 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,534 | 32,072 | 26,700 | 29,290 | N/A |
| Deferred Revenues | 2,619 | 11,698 | 10,137 | 3,874 | 11,410 |
| Other Non-Current Liabilities | 54,437 | 60,874 | 59,140 | 53,062 | 4,489 |
| TOTAL | $86,971 | $94,192 | $91,462 | $82,352 | $5,986 |
| Total Liabilities | $105,666 | $130,148 | $121,282 | $99,657 | $27,329 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,902 | 56,591 | 47,882 | 24,226 | 23,977 |
| Common Shares | 6 | 6 | 5 | 3 | 3 |
| Retained earnings | -504,862 | -375,096 | -247,597 | -158,379 | -92,158 |
| Other shareholders' equity | 0 | 51 | 0 | 0 | 0 |
| TOTAL | $123,123 | $240,970 | $150,867 | $99,434 | $160,778 |
| Total Liabilities And Equity | $228,789 | $371,118 | $272,149 | $199,091 | $188,107 |